Drug interactions
Asenapine transdermal + Formoterol-mometasone
Severity: Moderate
Asenapine transdermal and Formoterol-mometasone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Asenapine can prolong the QT interval modestly, and formoterol may contribute to QT effects at high doses. The combined risk is small but relevant in patients with cardiac disease or electrolyte disturbances.
What this interaction means in plain words
Asenapine transdermal and Formoterol-mometasone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive effects on cardiac repolarization.
What to do
Monitor ECG and electrolytes in patients with additional QT risk factors. Avoid adding further QT-prolonging agents.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Asenapine transdermal and Formoterol-mometasone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Formoterol-mometasone
Frequently asked questions
Can I take Asenapine transdermal with Formoterol-mometasone?
MediHelp rates the interaction as moderate. Asenapine transdermal and Formoterol-mometasone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Asenapine can prolong the QT interval modestly, and formoterol may contribute to QT effects at high doses. The combined risk is small but relevant in patients with cardiac disease or electrolyte disturbances.
How serious is the interaction between Asenapine transdermal and Formoterol-mometasone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and electrolytes in patients with additional QT risk factors. Avoid adding further QT-prolonging agents.
What other medicines interact with Formoterol-mometasone?
MediHelp also lists interactions of Formoterol-mometasone with, for example, Amiodarone, Amisulpride, Amoxapine. The full list is on the Formoterol-mometasone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
